Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer.

MLA

Han, Chae Young, et al. “Nuclear HKII-P-P53 (Ser15) Interaction Is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer.” Cancers, vol. 13, no. 14, July 2021, p. 3399. EBSCOhost, https://doi.org/10.3390/cancers13143399.

APA

Han, C. Y., Patten, D. A., Kim, S. I., Lim, J. J., Chan, D. W., Siu, M. K. Y., Han, Y., Carmona, E., Parks, R. J., Lee, C., Di, L.-J., Lu, Z., Chan, K. K. L., Ku, J.-L., Macdonald, E. A., Vanderhyden, B. C., Mes-Masson, A.-M., Ngan, H. Y. S., Cheung, A. N. Y., & Song, Y. S. (2021). Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer. Cancers, 13(14), 3399. https://doi.org/10.3390/cancers13143399

Chicago

Han, Chae Young, David A. Patten, Se Ik Kim, Jung Jin Lim, David W. Chan, Michelle K. Y. Siu, Youngjin Han, et al. 2021. “Nuclear HKII-P-P53 (Ser15) Interaction Is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer.” Cancers 13 (14): 3399. doi:10.3390/cancers13143399.